European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 0.81% to 1,477.39 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking company trivago (TRVG), which rose 3.1% and 2%, respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company TotalEnergies (TTE), which were up 1.9% and 1.8%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and financial services company Banco Santander (SAN), which fell 7.6% and 3.7%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and telecommunications company Nokia (NOK), which dropped 3.3% and 2.4%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which advanced 4.5% and 4%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and oil and gas company BP (BP), which increased 2.5% and 1.4%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and communications company WPP (WPP), which lost 5.6% and 2.4% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and financial services company Lloyds Banking Group (LYG), which were down 1.9% and 1.8%, respectively.